Filing Details

Accession Number:
0001104659-23-055649
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-03 19:49:53
Reporting Period:
2023-05-01
Accepted Time:
2023-05-03 19:49:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1657312 Verona Pharma Plc VRNA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1836820 Claire Poll 3 More London Riverside
London X0 SE1 2RE
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-05-01 80,376 $2.58 1,979,063 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 774,256 Indirect By Trust
Footnotes
  1. Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  2. The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
  3. The price reported represents the sale price of the ADSs divided by eight (8).
  4. Consists of (i) 1,641,672 Ordinary Shares underlying RSUs (which are represented by 205,209 ADSs); (ii) 337,384 Ordinary Shares underlying 42,173 ADSs and (iii) 7 Ordinary Shares.
  5. Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.